Open AccessSix Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101
Author(s) -
Lawrence N. Shulman,
Constance Cirrincione,
Donald A. Berry,
Heather P. Becker,
Edith A. Perez,
Ruth O’Regan,
Silvana Martino,
James N. Atkins,
Erica L. Mayer,
Charles Schneider,
Gretchen Kimmick,
Larry Norton,
Hyman B. Muss,
Eric P. Winer,
Clifford A. Hudis
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/n8eq-4315
Subject(s) - paclitaxel , cyclophosphamide , breast cancer , medicine , oncology , doxorubicin , cancer , adjuvant chemotherapy , chemotherapy